Evidence map›Paper›PMID 39387652›Full record

ArticleEuropean heart journal2025

Electrocardiogram-based deep learning to predict mortality in paediatric and adult congenital heart disease.

Joshua Mayourian, Amr El-Bokl, Platon Lukyanenko, William G La Cava, Tal Geva, Anne Marie Valente, John K Triedman, Sunil J Ghelani

Abstract read
In one paragraph

Article in European heart journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Role of Artificial Intelligence in Congenital Heart Disease and Interventions.Journal of the Society for Cardiovascular Angiography & Interventions · 2025
    Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Joshua MayourianDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.
Amr El-BoklDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.
Platon LukyanenkoDepartment of Pediatrics, Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
William G La CavaDepartment of Pediatrics, Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Tal GevaDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.
Anne Marie ValenteDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.
John K TriedmanDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.
Sunil J GhelaniDepartment of Cardiology, Boston Children's Hospital, Boston, MA, USA.ORCID 0000-0002-4227-8823

Funding

RESEARCH TRAINING IN PEDIATRIC EMERGENCY MEDICINET32HD040128 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI Kenneth D. Mandl · 2001 to 2026
$5.0M
Multi-objective representation learning methods for interpetable predictions of patient outcomesusing electronic health recordsR00LM012926 · NLM · BOSTON CHILDREN'S HOSPITAL · PI LA CAVA, WILLIAM · 2021 to 2023
$710k
Boston Children's Hospital R00-LM012926Boston Children's Hospital Electrophysiology Research Education Fund R00-LM012926NICHD NIH HHS T32 HD040128NLM NIH HHSNLM NIH HHS R00 LM012926Thrasher Research FundThrasher Research Fund Early Career Award
6 · The paper itself

Abstract

BACKGROUND AND

aimsRobust and convenient risk stratification of patients with paediatric and adult congenital heart disease (CHD) is lacking. This study aims to address this gap with an artificial intelligence-enhanced electrocardiogram (ECG) tool across the lifespan of a large, diverse cohort with CHD.

methodsA convolutional neural network was trained (50%) and tested (50%) on ECGs obtained in cardiology clinic at the Boston Children's Hospital to detect 5-year mortality. Temporal validation on a contemporary cohort was performed. Model performance was evaluated using the area under the receiver operating characteristic and precision-recall curves.

resultsThe training and test cohorts composed of 112 804 ECGs (39 784 patients; ECG age range 0-85 years; 4.9% 5-year mortality) and 112 575 ECGs (39 784 patients; ECG age range 0-92 years; 4.6% 5-year mortality from ECG), respectively. Model performance (area under the receiver operating characteristic curve 0.79, 95% confidence interval 0.77-0.81; area under the precision-recall curve 0.17, 95% confidence interval 0.15-0.19) outperformed age at ECG, QRS duration, and left ventricular ejection fraction and was similar during temporal validation. In subgroup analysis, artificial intelligence-enhanced ECG outperformed left ventricular ejection fraction across a wide range of CHD lesions. Kaplan-Meier analysis demonstrates predictive value for longer-term mortality in the overall cohort and for lesion subgroups. In the overall cohort, precordial lead QRS complexes were most salient with high-risk features including wide and low-amplitude QRS complexes. Lesion-specific high-risk features such as QRS fragmentation in tetralogy of Fallot were identified.

conclusionsThis temporally validated model shows promise to inexpensively risk-stratify individuals with CHD across the lifespan, which may inform the timing of imaging/interventions and facilitate improved access to care.

Indexed as

Deep LearningElectrocardiographyHeart Defects, CongenitalAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMiddle AgedRisk AssessmentArtificial intelligenceCongenital heart diseaseElectrocardiogramMortalityRisk stratification

Identifiers

PMID39387652
PMCPMC11879189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.